Jakarta, August 2, 2021
Pregnant women are one of the most at-risk groups when exposed to COVID-19. In recent times, it was reported that a number of pregnant women who were confirmed positive for COVID-19 experienced severe symptoms and even died.
To protect pregnant women and their babies from COVID-19 infection, the Ministry of Health ensures that it will immediately provide COVID-19 vaccines to pregnant women. Efforts to provide COVID-19 vaccination targeting pregnant women have also been recommended by the National Immunization Expert Advisory Committee (ITAGI).
This policy is contained in Circular HK.02.01/I/2007/2021 concerning COVID-19 Vaccination for Pregnant Women and Screening Adjustments in the Implementation of COVID-19 Vaccination, which was signed by the Acting Director General of Disease Prevention and Control Maxi Rein Rondonuwu on 2 August 2021.
With the issuance of this regulation, the Ministry of Health instructs all Heads of Provincial Health Offices, Heads of District/City Health Offices, and heads of health service facilities that carry out COVID-19 vaccinations, to immediately start vaccinating pregnant women, especially in areas with high levels of transmission of COVID-19 cases. 19 high.
The regulation also explains that vaccination for pregnant women is included in special criteria. Therefore, the process of skinning/screening of the health status of the target before vaccination is carried out in more detail than other targets. The screening format on the control card for pregnant women has also been prepared by the Ministry of Health.
Vaccination for pregnant women will use the mRNA platform COVID-19 vaccine, namely Pfizer and Moderna, as well as the Sinovac inactivated platform vaccine. Of course, it will be adjusted to the type of vaccine available in Indonesia.
The first dose of COVID-19 vaccine will be given in the second trimester of pregnancy, and the second dose will be given according to the interval of the type of vaccine.
Just like the implementation of vaccination for other targets, the Government will carry out monitoring to find out if there are any side effects that arise from giving the COVID-19 vaccine to pregnant women.
Anticipating the occurrence of AEFIs, at every vaccination card post there is a contact person who can be contacted if there are complaints from vaccination recipients or can also report through vaccine security.kemkes.go.id.
The government will also cover the Post Immunization Adverse Events (KIPI) of COVID-19 that requires treatment and care at health facilities in accordance with medical indications and treatment protocols.
Corona Virus Hotline 119 ext 9. This news was broadcast by the Bureau of Communications and Public Services, Ministry of Health of the Republic of Indonesia. For further information, please contact the Halo Ministry of Health hotline number via hotline 1500-567, SMS 081281562620, facsimile (021) 5223002, 52921669, and email address [email protected] (MF)
Head of Communication and Community Service Bureau
drg. Widyawati, MKM
–
